Nexmos

About Nexmos

Nexmos is a Korean bio company founded in December 2014 and researches and develops various application technologies based on Aptamer (DNA).
Nexmos is focusing on research and development of early diagnosis devices for various diseases using aptamer, which is also called “chemical antibody”, with advantages such as stable structure, low production cost, minimization of immune rejection reaction compared with existing antibodies, and R&D of new compounds using aptamer.
YEAR FOUNDED:
2014
LEADERSHIP:
CEO: Nelson Son
CIBO: Soyun Park
CAO: Wan-Young Lee
CFO: Dennis Jun
CMO: Jake Seo